01723nam 2200421Ia 450 991069597930332120070716160029.0(CKB)5470000002374005(OCoLC)155854244(EXLCZ)99547000000237400520070716d2007 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierDrug safety[electronic resource] further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives /statement of Marcia Crosse[Washington, D.C.] :U.S. Govt. Accountability Office,[2007]13 pages digital, PDF fileTestimony ;GAO-07-856 TTitle from title screen (viewed on July 3, 2007)."For release ... May 9, 2007."Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.Includes bibliographical references.Drug safety DrugsSafety measuresDrugsSafety measuresGovernment policyUnited StatesDrugsSafety measures.DrugsSafety measuresGovernment policyCrosse Marcia1380679United States.Congress.House.Committee on Energy and Commerce.Subcommittee on Health.United States.Government Accountability Office.GPOGPOBOOK9910695979303321Drug safety3449630UNINA